Skip to content

A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study

A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02352610
Enrollment
20
Registered
2015-02-02
Start date
2015-03-31
Completion date
2018-04-30
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

carpometacarpal joints

Brief summary

A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) with an interference screw for thumb carpometacarpal arthritis

Detailed description

This study will be a prospective randomized trial done in a single academic center. The patients who meet the inclusion criteria and agree to participate in the trial will be scheduled for a first CMC joint procedure. The procedure, standard LRTI or LRTI with a biotenodesis screw, will be allocated in a randomized fashion in the operating room using a sealed opaque envelope. After the surgery the patient will be placed in a spica splint for 1-2 weeks. Following suture removal, a thumb spica cast will be applied for immobilization for a total of 6 weeks of post-operative immobilisation. The potential population for this study will include all patients with first carpometacarpal joint arthritis that have failed a conservative treatment. The primary outcome will be the thumb subsidence measured as the percentage of trapezial height, which correlates with stability. Subsidence will be measured on stress x-ray under a standard pinch load. Secondary outcomes will be function measured in 4 different ways: the range of motion compared to the contralateral side, pinch and grip strength compared to the other side, the Disabilities of the Arm Shoulder and Hand (DASH) score and the pain score on a visual analogue scale.

Interventions

PROCEDURELRTI
DEVICEBiotenodesis Screw

Sponsors

Andrew Trenholm
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* First CMC primary osteoarthritis refractory to conservative treatment * Patient \>age 18 * Able to read and understand English * Available for 2 year follow up

Exclusion criteria

* Inflammatory Arthritis * Active infection in the first CMC joint * Concomitant neuropathy * Previous surgical procedure on the thumb * Active or status post CRPS * Severe ¨Z ¨deformity that requires palmar plate advancement * Unwilling to participate in a research project * Contralateral first CMC joint surgery

Design outcomes

Primary

MeasureTime frameDescription
Subsidence of CMC joint6 weeks, 3 months, 6 months, 1 year, 2 yearsMeasurement of trapezial height as a percentage of pre-operative height

Secondary

MeasureTime frameDescription
EQ-5D Health Questionnaire ScoreBaseline, 6 weeks, 3 months, 6 months, 1 year, 2 years
DASH questionnaire scoreBaseline, 6 weeks, 3 months, 6 months, 1 year, 2 years
Grip strength as measured by dynamometerBaseline, 3 months, 6 months, 1 year, 2 years
Pinch strength as measured by dynamometerBaseline, 3 months, 6 months, 1 year, 2 years
Radial abduction as measured by goniometerBaseline, 3 months, 6 months, 1 year, 2 yearsthumb range of motion
Palmar abduction as measured by goniometerBaseline, 3 months, 6 months, 1 year, 2 yearsthumb range of motion
Pain score on the visual analogue scaleBaseline, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 yearsvisual analogue scale
Opposition as measured by goniometerBaseline, 3 months, 6 months, 1 year, 2 yearsthumb range of motion

Other

MeasureTime frame
Number of participants with Adverse EventsBaseline, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026